Theiss et al. [24] reported that the elevation of prohibitin in the surface epithelial cells of the colon could reduce the severity of colitis in mice, suggesting that prohibitin might represent a novel therapeutic target in inflammatory bowel disease. The gene discussed is PHB1; the disease is colitis.